title: [News in digestive oncology].
abstract: Results published in 2007 improve treatments in digestive oncology. In esophageal cancer, efficacy of preoperative chemotherapy or radiochemotherapy is confirmed. In locally advanced esophageal cancer it has been proved that the definitive radiochemotherapy is an alternative at radiochemotherapy plus surgery. Two majors data have been presented for patients with metastatic colorectal cancer: monochemotherapy for the first line is back; molecular marker is necessary to optimize the use of anti EGFR antibody. Lastly, the first effective medical treatment of hepatocellular carcinoma has been presented.
authors.affiliation: Unité d'oncologie urodigestive, service d'hépato-gastroentérologie, Hôpital universitaire, 1, rue de Germont, 76031 Rouen Cedex, France. pierre.michel@chu-rouen.fr
authors.forename: Pierre
authors.initials: P
authors.lastname: Michel
authors.forename: Frédéric
authors.initials: F
authors.lastname: Di Fiore
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002299:Cardia; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy / Q000379:methods; D004067:Digestive System Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D004938:Esophageal Neoplasms / Q000628:therapy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D009536:Niacinamide / Q000031:analogs & derivatives; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use; D000077157:Sorafenib; D013274:Stomach Neoplasms / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib